Mamata Banerjee writes to PM Modi for expediting WHO nod to Covaxin

The CM, in her letter, stated that her government has been "receiving both Covishield and Covaxin" from the very beginning.

covaxin, bharat biotech, coronavirus vaccine, covid-19, vaccination
Press Trust of India Kolkata
2 min read Last Updated : Jun 24 2021 | 5:18 PM IST

Bengal Chief Minister Mamata Banerjee on Thursday wrote to Prime Minister Narendra Modi seeking his intervention for early approval of Covaxin by the World Health Organisation, without which people having taken the Bharat Biotech jab may face problems travelling abroad.

The CM, in her letter, stated that her government has been "receiving both Covishield and Covaxin" from the very beginning.

Even the private sector in the state has procured and administered both the vaccines, she said.

"A large number of students from all over the country travel abroad every year for higher studies and many of them have got themselves vaccinated with Covaxin.

"They came to learn later on that their vaccination certificate is not valid abroad. These students are now in a fix regarding their next course of action and their career is at stake," Banerjee wrote to Modi on Thursday.

Many countries are allowing entry of only those people who have taken WHO-approved vaccines, she noted.

"It is learnt that Covaxin is still not approved by WHO and it is not possible to travel abroad as many countries are allowing only those people who are fully vaccinated with WHO-approved vaccines.

"Hence, I request for your kind intervention so that an early approval is received for Covaxin from WHO so that students do not face any problem. This will also benefit people travelling abroad for job, education, business and any other purposes as well," she added.

Banerjee had on Wednesday asked Chief Secretary HK Dwidevi to write to the Union Health Secretary and Cabinet Secretary on this matter.

She had also urged the Centre to take steps to ensure that people inoculated with Covaxin do not face any restriction during their overseas travel.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Mamata BanerjeeNarendra ModiCoronavirus Vaccine

First Published: Jun 24 2021 | 5:18 PM IST

Next Story